Number of patients	Number of admissions	Number of adverse events
	152	581
Adverse events, n	10*	16	24
Serious adverse events, n	1	1	1†
Non‐serious adverse events, n	10	15	23
*One patient experienced non‐serious adverse events and a serious adverse event resulting in a total of 10 patients reporting adverse events. †Generalized hives; treatment related to a bleeding episode. GTR, Glanzmann’s Thrombasthenia Registry; rFVIIa, recombinant activated factor VII (NovoSeven®)